What are the advantages and disadvantages of interventional treatment for liver cancer? Revealing several advantages and disadvantages of interventional treatment for liver cancer

In recent years, liver cancer has become one of the major diseases that endanger society and human health, and it has brought great pain and distress to mankind. In order to reduce the incidence of liver cancer, interventional treatment of liver cancer is very necessary. The advantages of interventional treatment of liver cancer are roughly as follows: 1. The effect is definite. Those who are successfully treated can see a rapid decrease in AFp, a reduction in tumors, and a reduction in pain. 2. Scientific mechanism: The local drug concentration of interventional treatment is dozens of times higher than that of systemic chemotherapy, and it blocks the blood supply to the tumor. Therefore, it has a good two-pronged effect and less toxicity than systemic chemotherapy. 3. Interventional treatment of liver cancer is simple, easy to operate, safe and reliable. 4. It can be performed even for the elderly, the weak and those with certain diseases, without general anesthesia, and they need to stay awake. 5. The diagnostic angiography is clear and can be repeated, which is convenient for multiple comparisons. 6. For some liver cancers, the volume can be reduced and then resected in two steps. 7. It can be used as one of the important means of comprehensive treatment of advanced tumors. 8. The cost of interventional treatment of liver cancer is relatively low.

However, interventional treatment of liver cancer is not perfect either. Its main disadvantages are: 1. Despite super-selective entry, there are still obvious side effects, with the most reactions in the digestive tract, which brings discomfort to the human body; 2. Liver cancer mainly relies on the hepatic artery for blood supply, but there is portal vein blood supply around the cancer mass, so that cancer cells can survive secretly; 3. The operation is somewhat difficult, and the catheter should super-selectively enter the blood supply artery for better efficacy, but sometimes it is difficult to enter the hepatic artery, and some liver cancers can be supplied by multiple blood vessels.